Matt Lewis, MD

“Genomic medicine has the potential to transform the care of patients with congenital heart disease. Patient-centered research organizations, not providers or Universities, have the greatest ability to lead this charge and lay the foundation for future breakthroughs.  The CHI registry’s network offers our best hope to lead patient-centered genetic research and the inspiring efforts of all participants to date gives me hope that the next generation of advances is within reach.” — Matt Lewis, MD, cardiologist